Use of Insulin Sensitizers in NASH

Mouen Khashab, Naga Chalasani

Research output: Contribution to journalArticle

Abstract

This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

Original languageEnglish (US)
Pages (from-to)1067-1087
Number of pages21
JournalEndocrinology and Metabolism Clinics of North America
Volume36
Issue number4
DOIs
StatePublished - Dec 2007
Externally publishedYes

Fingerprint

Natural History
Liver
Insulin
Safety
Non-alcoholic Fatty Liver Disease

ASJC Scopus subject areas

  • Endocrinology
  • Biochemistry

Cite this

Use of Insulin Sensitizers in NASH. / Khashab, Mouen; Chalasani, Naga.

In: Endocrinology and Metabolism Clinics of North America, Vol. 36, No. 4, 12.2007, p. 1067-1087.

Research output: Contribution to journalArticle

@article{9c3a2ca572f04eab8cb81ce0084c2f15,
title = "Use of Insulin Sensitizers in NASH",
abstract = "This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.",
author = "Mouen Khashab and Naga Chalasani",
year = "2007",
month = "12",
doi = "10.1016/j.ecl.2007.07.006",
language = "English (US)",
volume = "36",
pages = "1067--1087",
journal = "Endocrinology and Metabolism Clinics of North America",
issn = "0889-8529",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Use of Insulin Sensitizers in NASH

AU - Khashab, Mouen

AU - Chalasani, Naga

PY - 2007/12

Y1 - 2007/12

N2 - This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

AB - This article briefly discusses nonalcoholic fatty liver disease (NAFLD) and its association with the metabolic syndrome, its pathogenesis and natural history. It then presents a detailed discussion on the efficacy and safety of different insulin sensitizers in patients who have NASH.

UR - http://www.scopus.com/inward/record.url?scp=35648951688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35648951688&partnerID=8YFLogxK

U2 - 10.1016/j.ecl.2007.07.006

DO - 10.1016/j.ecl.2007.07.006

M3 - Article

C2 - 17983937

AN - SCOPUS:35648951688

VL - 36

SP - 1067

EP - 1087

JO - Endocrinology and Metabolism Clinics of North America

JF - Endocrinology and Metabolism Clinics of North America

SN - 0889-8529

IS - 4

ER -